ArticleJournal of experimental & clinical cancer research : CR2020

SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.